Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ:IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), 4D Molecular Therapeutics Inc (NASDAQ:FDMT), Monopar Therapeutics Inc (NASDAQ:MNPR), Altimmune Inc (NASDAQ:ALT) and Prothena Corp PLC (NASDAQ:PRTA).
Ironwood Pharmaceuticals has a consensus price target of $9.96.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $3.47 last updated December 16, 2025 at 4:12 PM EST.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.